Advaxis, Merck to Collaborate on Investigational Combination of Two Novel Immunotherapy Candidates for Advanced Prostate Cancer
August 25, 2014 at 05:26 AM EDT
Advaxis (Nasdaq: ADXS) has entered into a clinical trial collaboration agreement with Merck (NYSE: MRK) to evaluate the combination of ...
